OTC Pharmaceuticals - Chile

  • Chile
  • The OTC Pharmaceuticals market in Chile is projected to reach a revenue of €566.30m in 2024.
  • It is expected to grow annually by 4.09% (CAGR 2024-2029).
  • Among the various markets in the market, the Other OTC Pharmaceuticals market holds the largest market share, with a volume of €187.80m in 2024.
  • In comparison to other countries, the in the United States generates the highest revenue in the OTC Pharmaceuticals market, amounting to €37,850.00m in 2024.
  • When considering the population, the per person revenue in Chile is estimated to be €28.80 in 2024.
  • Furthermore, online sales are expected to contribute 12.71% of the total revenue in the OTC Pharmaceuticals market by 2024.
  • Chile's OTC Pharmaceuticals market is witnessing a growing demand for natural remedies and herbal supplements.

Key regions: United States, China, Germany, Japan, Europe

 
Marché
 
Région
 
Comparaison de régions
 
Monnaie
 

Analyst Opinion

The OTC Pharmaceuticals market in Chile has been experiencing significant growth in recent years.

Customer preferences:
Chilean consumers have shown a growing preference for over-the-counter (OTC) medications due to their convenience and accessibility. OTC drugs provide consumers with the ability to self-diagnose and self-medicate minor ailments without the need for a prescription. This convenience factor has contributed to the increasing popularity of OTC medications in Chile.

Trends in the market:
One major trend in the OTC Pharmaceuticals market in Chile is the growing demand for natural and herbal remedies. Consumers are becoming more health-conscious and are seeking alternative treatments that are perceived to be safer and more natural. This trend is driven by a desire for products that have minimal side effects and are perceived to be more gentle on the body. As a result, there has been an increase in the availability and variety of natural and herbal OTC medications in the market.Another trend in the market is the rise of online sales of OTC medications. The increasing penetration of the internet and smartphones in Chile has led to a shift in consumer behavior, with more people opting to purchase their medications online. Online platforms provide consumers with a wide range of options, competitive prices, and the convenience of doorstep delivery. This trend is expected to continue as e-commerce continues to grow in popularity in Chile.

Local special circumstances:
Chile has a well-developed healthcare system with a high level of access to healthcare services. However, the public healthcare system is often overwhelmed, leading to long wait times for doctor appointments and limited access to prescription medications. This has contributed to the popularity of OTC medications as an alternative option for consumers to manage their health conditions. Additionally, the high cost of prescription medications has also incentivized consumers to opt for OTC alternatives.

Underlying macroeconomic factors:
Chile has experienced steady economic growth in recent years, resulting in an increase in disposable income levels. This has allowed consumers to spend more on healthcare products, including OTC medications. The growing middle class in Chile has also contributed to the increased demand for OTC pharmaceuticals, as these products are more affordable compared to prescription medications.In conclusion, the OTC Pharmaceuticals market in Chile is experiencing growth due to customer preferences for convenience and accessibility, the trend towards natural and herbal remedies, the rise of online sales, the local special circumstances of the healthcare system, and the underlying macroeconomic factors of economic growth and increased disposable income.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Vue d’ensemble

  • Revenue
  • Analyst Opinion
  • Key Players
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Veuillez patienter

Contact

Des questions ? Nous nous ferons un plaisir de vous aider.
Statista Locations
Contact Camille Dubois
Camille Dubois
Customer Relations

Lun - Ven, 9:00 - 18:00 h (EST)

Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (États-Unis)

Lun - Ven, 9:00 - 18:00 h (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asie)

Lun - Ven, 9:00 - 17:00 h (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asie)

Lun - Ven, 10:00 - 18:00 h (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Lun - Ven, 9:00 - 18:00 h (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Amérique latine)

Lun - Ven, 9:00 - 18:00 h (EST)